Attavia Clinical Software
Monitoring — no action neededHealthcare Technology · Madison, WI
Jun 11 – Aug 13, 2026
10 weeks of telemetry
Attavia Clinical Software is 29 points below its escalation threshold — cross-functional communication is the strongest theme at 42 against a threshold of 71. Nothing is currently escalated, though 1 theme is still climbing. No board direction is outstanding.
42
Highest signal
of 71 threshold
0
Open escalations
nothing open
80%
Participation
coverage sufficient
0
Board actions
none assigned
What needs attention
2 active themesCross-Functional Communication
7 independent participants · 4 functions
Reported by 7 independent participants across 4 functions, persistent for 4 weeks and rising.
Leadership Direction Clarity
6 independent participants · 4 functions
Reported by 6 independent participants across 4 functions, persistent for 4 weeks.
Organizational radar
all 8 themes scored0
Escalated
1
Developing
Cross-Functional Communication
7
Quiet
View all eight themesHide view all eight themes
Organizational radar
Attavia Clinical Software across the eight themes
Every company is scored on the same eight themes, shaded against this program's own escalation threshold — so a quiet row means quiet, not unmeasured.
Confidence = unique reporters of a theme ÷ active participants over the rolling 4-week window. A cell turns red once it crosses its company's escalation threshold.
Board response
No board direction outstanding, and nothing open that needs one.
bolt-on · held since June 2023 · Madison, WI
Company contextHide company context
- Employees
- 155
- Signal seats
- 20
- 13% enrolled
- Revenue
- $29M ARR
- EBITDA margin
- 14–17%
Investment thesis
Clinical documentation module acquired to close a competitive gap in Solverance enterprise deals.
Known exposures
- ·Product integration dependent on four engineers from the acquired team
Signal data is PE-exclusive. Portfolio company leadership has no visibility into submissions, themes, or confidence scores.
Beacon detects. Bearing interprets. You decide.